Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-12-08 Sale |
2022-12-12 1:39 pm |
Virios Therapeutics Inc. | VIRI | Whitley Richard James Director |
1,800 | $0.2591 | $466 | 700 (Direct) |
View |
2022-05-23 Purchase |
2022-05-24 2:53 pm |
Virios Therapeutics Inc. | VIRI | Walsh Angela SVP OF FINANCE |
2,000 | $4.575 | $9,150 | 3,000 (Indirect) |
View |
2022-05-23 Purchase |
2022-05-24 10:24 am |
Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER |
7,500 | $4.52 | $33,900 | 32,461 (Direct) |
View |
2022-05-18 Purchase |
2022-05-19 11:48 am |
Virios Therapeutics Inc. | VIRI | Whitley Richard James Director |
500 | $4.525 | $2,263 | 2,500 (Direct) |
View |
2022-05-18 Purchase |
2022-05-19 11:44 am |
Virios Therapeutics Inc. | VIRI | Pridgen William Director |
241 | $4.5 | $1,085 | 745,944 (Indirect Direct) |
View |
2022-05-17 Purchase |
2022-05-18 11:24 am |
Virios Therapeutics Inc. | VIRI | Pridgen William Director |
13,450 | $4.3802 | $58,914 | 745,703 (Indirect Direct) |
View |
2022-03-29 Purchase |
2022-03-30 11:55 am |
Virios Therapeutics Inc. | VIRI | Pridgen William Director |
600 | $4.9408 | $2,964 | 732,253 (Indirect Direct) |
View |
2022-03-23 Purchase |
2022-03-24 2:52 pm |
Virios Therapeutics Inc. | VIRI | Pridgen William Director |
2,197 | $5.4627 | $12,002 | 731,653 (Indirect Direct) |
View |
2022-01-27 Purchase |
2022-01-28 3:30 pm |
Virios Therapeutics Inc. | VIRI | Pridgen William Director |
4,180 | $5.9803 | $24,998 | 729,456 (Indirect Direct) |
View |
2022-01-07 Purchase |
2022-01-07 5:24 pm |
Virios Therapeutics Inc. | VIRI | De La Rosa Abel Director |
4,000 | $5.896 | $23,584 | 4,000 (Direct) |
View |
2022-01-06 Purchase |
2022-01-07 1:14 pm |
Virios Therapeutics Inc. | VIRI | Whitley Richard James Director |
1,800 | $5.72 | $10,296 | 2,000 (Direct) |
View |
2022-01-04 Purchase |
2022-01-05 3:12 pm |
Virios Therapeutics Inc. | VIRI | Keefer David R Director |
5,000 | $5.795 | $28,975 | 12,808 (Indirect Direct) |
View |
2022-01-03 Purchase |
2022-01-04 3:23 pm |
Virios Therapeutics Inc. | VIRI | Pridgen William Director |
2,215 | $5.4329 | $12,034 | 725,276 (Indirect Direct) |
View |
2022-01-04 Purchase |
2022-01-04 3:19 pm |
Virios Therapeutics Inc. | VIRI | Thomas John C Director |
1,000 | $5.65 | $5,650 | 1,000 (Direct) |
View |
2021-12-23 Purchase |
2021-12-23 3:59 pm |
Virios Therapeutics Inc. | VIRI | Whitley Richard James Director |
200 | $5.725 | $1,145 | 200 (Direct) |
View |
2021-12-21 Purchase |
2021-12-22 1:28 pm |
Virios Therapeutics Inc. | VIRI | Pridgen William Director |
8,827 | $5.6641 | $49,997 | 723,061 (Indirect Direct) |
View |
2021-12-21 Purchase |
2021-12-22 1:23 pm |
Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER |
5,000 | $5.523 | $27,615 | 24,961 (Direct) |
View |
2021-07-07 Purchase |
2021-07-09 1:36 pm |
Virios Therapeutics Inc. | VIRI | Pridgen William Director |
942 | $6.317 | $5,951 | 714,234 (Indirect Direct) |
View |
2021-04-06 Purchase |
2021-04-07 1:59 pm |
Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott Chief Executive Officer |
382 | $6.3576 | $2,429 | 19,961 (Direct) |
View |
2021-04-05 Purchase(A) |
2021-04-06 9:56 pm |
Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott Chief Executive Officer |
15,675 | $6.1727 | $96,757 | 19,579 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-06-23 Option Award |
2022-06-30 2:09 pm |
N/A 2032-06-23 |
Virios Therapeutics Inc. | VIRI | Whitley Richard James Director |
5,250 | $0 | 5,250 (Direct) |
View |
2022-06-23 Option Award |
2022-06-30 2:08 pm |
N/A 2032-06-23 |
Virios Therapeutics Inc. | VIRI | Pridgen William Director |
5,250 | $0 | 5,250 (Direct) |
View |
2022-06-23 Option Award |
2022-06-30 2:05 pm |
N/A 2032-06-23 |
Virios Therapeutics Inc. | VIRI | Burch Richard Alan Director |
5,250 | $0 | 5,250 (Direct) |
View |
2022-06-23 Option Award |
2022-06-30 2:03 pm |
N/A 2032-06-23 |
Virios Therapeutics Inc. | VIRI | Keefer David R Director |
5,250 | $0 | 5,250 (Direct) |
View |
2022-06-23 Option Award |
2022-06-30 2:01 pm |
N/A 2032-06-23 |
Virios Therapeutics Inc. | VIRI | Thomas John C Director |
5,250 | $0 | 5,250 (Direct) |
View |
2022-06-23 Option Award |
2022-06-30 1:59 pm |
N/A 2032-06-23 |
Virios Therapeutics Inc. | VIRI | De La Rosa Abel Director |
5,250 | $0 | 5,250 (Direct) |
View |
2022-06-23 Option Award |
2022-06-30 1:53 pm |
N/A 2032-06-23 |
Virios Therapeutics Inc. | VIRI | Gendreau Roger Michael CHIEF MEDICAL OFFICER |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-30 1:43 pm |
N/A 2032-06-23 |
Virios Therapeutics Inc. | VIRI | Grosswald Ralph SVP OF OPERATIONS |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-30 1:40 pm |
N/A 2032-06-23 |
Virios Therapeutics Inc. | VIRI | Walsh Angela SVP OF FINANCE |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-30 1:38 pm |
N/A 2032-06-23 |
Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER |
90,000 | $0 | 90,000 (Direct) |
View |
Ownership |
2022-02-14 3:03 pm |
N/A N/A |
Virios Therapeutics Inc. | VIRI | Burch Richard Alan Director |
0 | $0 | 147,681 (Direct) |
View |
2021-06-22 Option Award |
2021-06-23 3:26 pm |
N/A 2031-06-22 |
Virios Therapeutics Inc. | VIRI | Pridgen William Director |
7,875 | $0 | 7,875 (Direct) |
View |
2021-06-22 Option Award |
2021-06-23 2:59 pm |
N/A 2031-06-22 |
Virios Therapeutics Inc. | VIRI | Burch Richard Alan Director |
7,875 | $0 | 7,875 (Direct) |
View |
2021-06-22 Option Award |
2021-06-23 2:55 pm |
N/A 2031-06-22 |
Virios Therapeutics Inc. | VIRI | Whitley Richard James Director |
7,875 | $0 | 7,875 (Direct) |
View |
2021-06-22 Option Award |
2021-06-23 2:52 pm |
N/A 2031-06-22 |
Virios Therapeutics Inc. | VIRI | Thomas John C Director |
7,875 | $0 | 7,875 (Direct) |
View |
2021-06-22 Option Award |
2021-06-23 2:48 pm |
N/A 2031-06-22 |
Virios Therapeutics Inc. | VIRI | Keefer David R Director |
7,875 | $0 | 7,875 (Direct) |
View |
2021-06-22 Option Award |
2021-06-23 2:42 pm |
N/A 2031-06-22 |
Virios Therapeutics Inc. | VIRI | De La Rosa Abel Director |
7,875 | $0 | 7,875 (Direct) |
View |
2021-06-21 Option Award |
2021-06-22 5:05 pm |
N/A 2031-06-21 |
Virios Therapeutics Inc. | VIRI | Walsh Angela SVP OF FINANCE |
30,000 | $0 | 30,000 (Direct) |
View |
2021-06-21 Option Award |
2021-06-22 5:01 pm |
N/A 2031-06-21 |
Virios Therapeutics Inc. | VIRI | Grosswald Ralph VICE PRESIDENT OF OPERATIONS |
30,000 | $0 | 30,000 (Direct) |
View |
2021-06-21 Option Award |
2021-06-22 4:58 pm |
N/A 2031-06-21 |
Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER |
60,000 | $0 | 60,000 (Direct) |
View |